Wen Jiang, M.D., Ph.D.
The University of Texas Southwestern Medical Center
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR180017|
Recruitment of First-Time, Tenure-Track Faculty Members
The University of Texas MD Anderson Cancer Center
February 21, 2018
Immunotherapy has provided new hope for a permanent cure for some cancers, but as few as 20 percent of patients treated with immunotherapy ultimately respond to the treatment. And some types of cancer — like breast, prostate, and pancreatic cancers — typically don’t respond at all.
Physician scientist Dr. Wen Jiang hopes to engage the immune system using nanomaterials to combat immune-therapy–resistant cancers. He plans to start with some of the most intractable, including treatment-resistant and metastatic breast cancers.
Dr. Jiang was recruited in 2018 from The University of Texas MD Anderson Cancer Center, where he was a resident in radiation oncology, to The University of Texas Southwestern Medical Center. A First-Time Tenure-Track Award from CPRIT enabled this promising young researcher to remain in Texas.